Symberix
Careers
About Symberix Management Team Advisory Board
What is the Microbiome? Symbiotic Drugs
News Publications
Contact Us Policies
About About Symberix Management Team Advisory Board Science What is the Microbiome? Symbiotic Drugs
Symberix
News News Publications Connect Contact Us Policies Careers
magazine-806073_1920.jpg

Publications

2018

  • July 2018
    Gut Microbial Beta-Glucuronidase Inhibition via Catalytic Cycle Interception

  • May 2018
    Microbial Glucuronidase Inhibition Reduces Severity of Diclofenac-Induced Anastomotic Leak

  • January 2018
    Structural Basis for the Regulation of Beta-Glucuronidase Expression by Human Gut Enterobacteriaceae

2017

  • July 2017
    An Atlas of Beta-Glucuronidases in the Human Intestinal Microbiome

  • February 2017
    Review: Microbial Molecules from the Multitudes within Us

2015

  • December 2015
    Structure and Inhibition of Microbiome Beta-Glucuronidases

2014

  • January 2014
    Beta-Glucuronidase Inhibition Protects Mice Against NSAID-Induced Enteropathy

2013

  • August 2013
    Molecular Insights into Microbial Beta-Glucuronidase Inhibition to Abrogate CPT-11 Toxicity

  • June 2013
    The Human Microbiome is a Source of Therapeutic Drug Targets

2012

  • May 2012
    Pharmacologic Targeting of Bacterial Beta-Glucuronidase Alleviates NSAID-Induced Enteropathy

2010

  • November 2010
    Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme

Careers
Contact
Policies
Hours

Symberix, Inc.
4819 Emperor Blvd, #400
Durham, NC 27703

Icons by icons8.